Home » Newsletters » BioWorld Science

BioWorld Science

May 25, 2017

View Archived Issues

EMA committee recommends orphan drug designation for MK-0677

GABA(A) positive allosteric modulator shows promise in irritable bowel syndrome model

Bioverativ to acquire True North Therapeutics and obtain worldwide rights to TNT-009

European Commission grants marketing authorization for Axumin

Pfizer gene therapy granted U.S. orphan designation for Duchenne muscular dystrophy

Ninlaro capsules become available in Japan for the treatment of multiple myeloma

Preliminary results show nearly 100% immune response rates in clinical study of Pennvax-GP

miRagen Therapeutics' MRG-106 named orphan medicinal product in E.U.

Liquidia Technologies reports positive results from phase I study of LIQ-865

RDX-8940, an improved GPBAR1 agonist for treating NAFLD/NASH

FDA committee recommends approval of Endari for sickle cell disease

FDA awards fast track designation to CM-4620 for acute pancreatitis

Radius Health reports topline results from Tymlos extension trial

FDA committee recommends approval of neratinib in HER2-positive breast cancer

HitGen forms drug discovery collaboration with Scripps Research Institute and Calibr

Aronora initiates phase I study of xisomab 3G3

EMA awards orphan drug designation to Actinium's Actimab-A

T-cell differentiation antigen CD6, a potential target for treating multiple sclerosis

ProtoKinetix gives update on its testing of retinal replacement therapy with AAGP

Aerie reports phase III topline results from MERCURY 2 study of Roclatan

Protagonist Therapeutics receives SBIR grant to develop biomarkers of IL-23R antagonist activity

FDA grants priority review to sBLA for Opdivo in previously treated HCC

Concert Pharmaceuticals shareholders approve CTP-656 asset purchase agreement with Vertex

Mundipharma launches Mundesine in Japan

Phase II study evaluates oral levosimendan in amyotrophic lateral sclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...